Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Shelley Wood

November 13, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Yael L. Maxwell

September 05, 2023

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News CV Team Pro

Viet Le

L.A. McKeown

July 07, 2023

News Daily News

Method to Overcome CAC Score Variability Hones Risk Stratification

Todd Neale

June 26, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

Advertisement

Mortality Risk Varies Among Patients With Very High LDL Levels

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

October 2023 News Roundup

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Viet Le

Method to Overcome CAC Score Variability Hones Risk Stratification

FDA Approves Colchicine for Decreasing CV Events

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content